Do you need a pharmacokinetic model, and, if so, which one?

As part of the defense of the first thesis, a survey will be made of the simple pharmacokinetic models. Figure 1 shows the linear mammillary disposition models with from one to three compartments. A disposition model is one representing bolus intravenous administration of the drug. In each case, the concentration in compartment 1 is assumed to represent the whole blood (plasma or serum) concentration of unchanged drug. There is only one "one-compartment open model"; there are three different "two-compartment open models"; there are 13 "three-compartment open models." Within each class, the differences between the models resides in the compartment or compartments from which

[1]  A. Rescigno,et al.  Drug and tracer kinetics , 1966 .

[2]  M. Rowland,et al.  Influence of route of administration on drug availability. , 1972, Journal of pharmaceutical sciences.

[3]  John G. Wagner,et al.  Application of the Loo-Riegelman absorption method , 1975, Journal of Pharmacokinetics and Biopharmaceutics.

[4]  J. Wagner,et al.  Blood Levels of Drug at the Equilibrium State after Multiple Dosing , 1965, Nature.

[5]  J. Wagner,et al.  Pharmacokinetics of highly ionized drugs. 3. Methylene blue--blood levels in the dog and tissue levels in the rat following intravenous administration. , 1972, Journal of pharmaceutical sciences.

[6]  J. Wagner,et al.  Pharmacokinetics of highly ionized drugs. I. Methylene blue--whole blood, urine, and tissue assays. , 1972, Journal of pharmaceutical sciences.

[7]  E. Krüger-Thiemer,et al.  Formal theory of drug dosage regimens. I , 1966 .

[8]  J. Wagner Method of estimating relative absorption of a drug in a series of clinical studies in which blood levels are measured after single and/or multiple doses. , 1967, Journal of pharmaceutical sciences.

[9]  John G. Wagner,et al.  Application of the Wagner-Nelson absorption method to the two-compartment open model , 1974, Journal of Pharmacokinetics and Biopharmaceutics.

[10]  J. Wagner,et al.  Per cent absorbed time plots derived from blood level and/or urinary excretion data. , 1963, Journal of pharmaceutical sciences.

[11]  W. Jusko,et al.  Pharmacokinetic Design of Digoxin Dosage Regimens in Relation to Renal Function , 1974, Journal of clinical pharmacology.

[12]  J. Wagner,et al.  Pharmacokinetics of orally administered acetaminophen in man , 1974, Journal of Pharmacokinetics and Biopharmaceutics.

[13]  S. Riegelman,et al.  New method for calculating the intrinsic absorption rate of drugs. , 1968, Journal of pharmaceutical sciences.

[14]  K. Bischoff,et al.  Methotrexate pharmacokinetics. , 1971, Journal of pharmaceutical sciences.

[15]  J. Wagner,et al.  Pharmacokinetics of diphenhydramine in man , 1975, Journal of Pharmacokinetics and Biopharmaceutics.

[16]  J. Wagner,et al.  Quantitative pooling of Michaelis-Menten equations in models with parallel metabolite formation paths , 1974, Journal of Pharmacokinetics and Biopharmaceutics.

[17]  L. Benet,et al.  General treatment of linear mammillary models with elimination from any compartment as used in pharmacokinetics. , 1972, Journal of pharmaceutical sciences.

[18]  S Zietz,et al.  Curve fitting by spline and Akima methods: possibility of interpolation error and its suppression. , 1973, Physics in medicine and biology.

[19]  John G. Wagner,et al.  Properties of the Michaelis-Menten equation and its integrated form which are useful in pharmacokinetics , 1973, Journal of Pharmacokinetics and Biopharmaceutics.

[20]  C. Ginneken,et al.  Linear and nonlinear kinetics of drug elimination I. Kinetics on the basis of a single capacity-limited pathway of elimination with or without simultaneous supply-limited elimination , 1974, Journal of Pharmacokinetics and Biopharmaceutics.